0001662388-16-000002.txt : 20160422 0001662388-16-000002.hdr.sgml : 20160422 20160421181807 ACCESSION NUMBER: 0001662388-16-000002 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20160422 DATE AS OF CHANGE: 20160421 EFFECTIVENESS DATE: 20160422 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Bioniz Therapeutics, Inc. CENTRAL INDEX KEY: 0001662388 IRS NUMBER: 272364515 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-254158 FILM NUMBER: 161584960 BUSINESS ADDRESS: STREET 1: 5 MASON STREET 2: SUITE 200 CITY: IRVINE STATE: CA ZIP: 92618 BUSINESS PHONE: 949-273-6000 MAIL ADDRESS: STREET 1: 5 MASON STREET 2: SUITE 200 CITY: IRVINE STATE: CA ZIP: 92618 D/A 1 primary_doc.xml X0707 D/A LIVE 0001662388 Bioniz Therapeutics, Inc. 5 MASON SUITE 200 IRVINE CA CALIFORNIA 92618 949-273-6000 DELAWARE Bioniz, LLC None Corporation true 2015 Nazli Azimi c/o Bioniz Therapeutics, Inc. 5 Mason, Suite 200 Irvine CA CALIFORNIA 92618 Executive Officer Director Joe Kiani c/o Bioniz Therapeutics, Inc. 5 Mason, Suite 200 Irvine CA CALIFORNIA 92618 Director David Pyott c/o Bioniz Therapeutics, Inc. 5 Mason, Suite 200 Irvine CA CALIFORNIA 92618 Director Kleanthis Xanthopoulos c/o Bioniz Therapeutics, Inc. 5 Mason, Suite 200 Irvine CA CALIFORNIA 92618 Director Ilan Zipkin c/o Bioniz Therapeutics, Inc. 5 Mason, Suite 200 Irvine CA CALIFORNIA 92618 Director Biotechnology Decline to Disclose 06b true 0001662388-15-000001 2015-12-17 false true false 0 15000000 5674998 9325002 false 9 0 0 0 false Bioniz Therapeutics, Inc. /s/ Nazli Azimi Nazli Azimi President & CEO 2016-04-20